Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
Seonghwan Hwang, Hwayoung Yun, Sungwon Moon, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
Moritz Peiseler, Robert F. Schwabe, Jochen Hampe, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1136-1160
Open Access | Times Cited: 287
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 764-783
Closed Access | Times Cited: 90
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101231-101231
Open Access | Times Cited: 53
Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease in male mice
Jonathan M. Weiss, Erika M. Palmieri, Marieli Gonzalez-Cotto, et al.
Nature Metabolism (2023) Vol. 5, Iss. 6, pp. 981-995
Open Access | Times Cited: 41
Hepatic Stellate Cell-Immune Interactions in NASH
James K. Carter, Scott L. Friedman
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 51
From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences
Ahmed Samy, Mohamed A. Kandeil, Dina Sabry, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30387-e30387
Open Access | Times Cited: 11
Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice
Hassam Ali, Muhammad Shahzil, Vishali Moond, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 61-61
Open Access | Times Cited: 9
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
Dechun Feng, Seonghwan Hwang, Adrien Guillot, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 3, pp. 101352-101352
Open Access | Times Cited: 8
Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease – A Population-based Cohort Study
Fahim Ebrahimi, Tracey G. Simon, Hannes Hagström, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 13, pp. 3346-3355.e19
Open Access | Times Cited: 19
Inflammatory processes involved in NASH-related hepatocellular carcinoma
Stefania Cannito, Umberto Dianzani, Maurizio Parola, et al.
Bioscience Reports (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 17
The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
Iulia Minciună, Madalina Gabriela Taru, Bogdan Procopeț, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1406-1406
Open Access | Times Cited: 7
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Anna Alisi, Geoffrey W. McCaughan, Henning Grønbæk
Hepatology International (2024) Vol. 18, Iss. S2, pp. 861-872
Closed Access | Times Cited: 7
Association between neutrophil-to-high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2017–2020
Na Zhu, Yanyan Li, Yingying Lin, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Neutrophil extracellular traps-triggered hepatocellular senescence exacerbates lipotoxicity in non-alcoholic steatohepatitis
Ming Xu, Hao Xu, Yu‐Wei Ling, et al.
Journal of Advanced Research (2025)
Open Access
The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis
Wei Du, Lin Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr−/−.Leiden mice with manifest obesity‐associated NASH
Eveline Gart, Wim van Duyvenvoorde, Martien Caspers, et al.
The FASEB Journal (2022) Vol. 36, Iss. 8
Open Access | Times Cited: 24
Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets
Yang Liu, Yawen Hao, Joost Boeckmans, et al.
Pharmacology & Therapeutics (2023) Vol. 243, pp. 108353-108353
Open Access | Times Cited: 14
Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation
Sara Novi, Vincenzo Vestuto, Pietro Campiglia, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2748-2748
Open Access | Times Cited: 13
NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis
Sonja Marinović, Maja Lenartić, Karlo Mladenić, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 12
The immune response as a therapeutic target in non-alcoholic fatty liver disease
Nicolás Ortiz‐López, Catalina Fuenzalida, María Soledad Dufeu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Antiangiogenic Effects of Natural Compounds in Hepatic Inflammation
Sara Novi, Vincenzo Vestuto, Pietro Campiglia, et al.
(2023)
Open Access | Times Cited: 10
Plasma Calprotectin Levels Associate with Suspected Metabolic-Associated Fatty Liver Disease and All-Cause Mortality in the General Population
Arno R. Bourgonje, Eline H. van den Berg, Lyanne M. Kieneker, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15708-15708
Open Access | Times Cited: 15
Mesenchymal stem cells-based therapy in liver diseases
Hengtong Han, Weilin Jin, Xun Li
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 14
The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook
Zhou Zhou, Yuhao Hu, Yixuan Wu, et al.
Molecular Immunology (2022) Vol. 151, pp. 218-230
Closed Access | Times Cited: 14
Pathogenesis from Inflammation to Cancer in NASH-Derived HCC
Simiao Yu, Jingxiao Wang, Haocheng Zheng, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 855-867
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top